Supernus Pharmaceuticals (SUPN) Preferred Dividend Payments (2011 - 2012)
Supernus Pharmaceuticals (SUPN) reported Preferred Dividend Payments of $286000.0 for Q2 2012, down 66.67% year-over-year from $858000.0 in Q3 2011, and down 66.67% quarter-over-quarter from $858000.0 in Q1 2012.
Supernus Pharmaceuticals (SUPN) Preferred Dividend Payments (2011 - 2012) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 2 years of Preferred Dividend Payments data on file, last reported at $286000.0 in Q2 2012.
- Preferred Dividend Payments for Q2 2012 came in at $286000.0, down 66.67% year-over-year; the trailing twelve-month figure through Dec 2012 was $1.1 million (down 66.66% YoY), and the FY2012 annual result was $1.1 million, down 66.68% from the prior year.
- Preferred Dividend Payments eased to $286000.0 in Q2 2012 per SUPN's latest filing, from $858000.0 in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $858000.0 in Q1 2011 and troughed at $286000.0 in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Supernus Pharmaceuticals | 2.57 Bn | 2.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2012 | 286,000.00 |
| Mar 31, 2012 | 858,000.00 |
| Dec 31, 2011 | 857,000.00 |
| Sep 30, 2011 | 858,000.00 |
| Jun 30, 2011 | 858,000.00 |
| Mar 31, 2011 | 858,000.00 |